Share
Entrepreneur
The COVID-19 vaccine may spell the end of the pandemic, but while mass vaccination is not available it is vital to stop community transmission. The new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress “completely” the transmission of the coronavirus in just 24 hours , according to studies by the Institute of Biomedical Sciences of Georgia State University.
“This is the first demonstration of an orally available drug that quickly blocks the transmission of SARS-CoV-2 , so it could be a game changer,” the researchers explained in the work published in the journal Nature Microbiology .
The antiviral drug was developed at Emory University in Atlanta by the drug innovation company Drug Innovation Ventures at Emory (DRIVE), which was licensed by Ridgeback Biotherapeutics, which partnered with Merck & Co. Molnupiravir was originally designed to treat the flu and prevent the virus from making copies of itself, creating errors during viral RNA replication.
RELATED TOPICS:
Categories
Fresno Man Facing Multiple Charges After Violent Freeway Pursuit and Shooting
Former Porterville Librarian Accused of Stealing Thousands From Elderly Friend
Fowler Felon Jailed After Officers Find Assault Rifle, Drugs in Home Search
Young People Drive Fresno to CA’s Top Job Growth: Wells Fargo Study
Judge Rejects Claim That Sean ‘Diddy’ Combs Was Treated Differently Because of His Race
